The Vanderbilt Kennedy Center researchers in this episode are studying the connection of Down syndrome and Alzheimer’s Disease. The Trial-Ready Cohort-Down Syndrome Study will identify individuals over age 35 with Down syndrome, obtain information about how they are functioning, and evaluate their brain activity and structure. This work will identify individuals with Down syndrome who may be eligible for a future medication study with the goal of reducing their risk for the development of Alzheimer’s disease.
VKC Researcher: Paul Newhouse, M.D., Jim Turner Professor of Cognitive Disorders; Professor of Psychiatry & Behavioral Sciences, Pharmacology, and Medicine; Director, Vanderbilt Center for Cognitive Medicine
Interviewer: Elise McMillan, J.D., Co-Director, Vanderbilt Kennedy Center for Excellence in Developmental Disabilities; Director of Community Engagement and Public Policy; and Senior Lecturer in Psychiatry & Behavioral Sciences
What is The Promise of Discovery?
“The Promise of Discovery” is a podcast hosted by the Vanderbilt Kennedy Center that highlights research in intellectual and developmental disabilities. The goals of the podcast are to host conversations about research in plain language and to highlight “real world” implications. The discussions cover why the research matters in the lives of people with disabilities and families, how the research impacts and enhances what we know already and/or raises additional questions in the field, and what implications the research might have for policy.